Risk-stratified seroprevalence of severe acute respiratory syndrome coronavirus among children in Hong Kong

Pediatrics

Volumn 117, Issue 6, 2006, Pages

  Lee, Pamela P W ^a   Wong, Wilfred H S ^a   Leung, Gabriel M ^a   Chiu, Susan S ^a   Chan, Kwok Hung ^a   Peiris, Joseph S M ^a   Lam, Tai Hing ^a   Lau, Yu Lung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Children; SARS; SARS coronavirus seroprevalence; Severe acute respiratory syndrome

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ANAMNESIS; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; HEALTH CARE UTILIZATION; HIGH RISK POPULATION; HONG KONG; HOUSEHOLD; HUMAN; IMMUNOFLUORESCENCE TEST; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NURSE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SARS CORONAVIRUS; SEROPREVALENCE; SEVERE ACUTE RESPIRATORY SYNDROME; TELEPHONE; TRAVEL; BLOOD; CORONAVIRUS; EPIDEMIOLOGY; IMMUNOLOGY; RISK FACTOR;

ADOLESCENT; ANTIBODIES, VIRAL; CHILD; CORONAVIRUS; FEMALE; HONG KONG; HUMANS; MALE; RISK ASSESSMENT; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 33745325242     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-1476     Document Type: Article

References (18)

1. Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319-1325
2. Leung GM, Hedley AJ, Ho LM, et al. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med. 2004;141:662-673
3. Leung CW, Kwan YW, Ko PW, et al. Severe acute respiratory syndrome among children. Pediatrics. 2004;113(6). Available at: www.pediatrics.org/cgi/ content/full/113/6/e535
4. Chang LY, Huang FY, Wu YC, et al. Childhood severe acute respiratory syndrome in Taiwan and how to differentiate it from childhood influenza infection. Arch Pediatr Adolesc Med. 2004;158:1037-1042
5. Wong GW, Li AM, Ng PC, Fok TF. Severe acute respiratory syndrome in children. Pediatr Pulmonol. 2003;36:261-266
6. Leung TF, Wong GW, Hon KL, Fok TF. Severe acute respiratory syndrome (SARS) in children: epidemiology, presentation and management. Paediatr Respir Rev. 2003;4:334-339
7. Leung CW, Chiu WK. Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children. Paediatr Respir Rev. 2004;5:275-288
8. Lai PC, Wong CM, Hedley AJ, et al. Understanding the spatial clustering of severe acute respiratory syndrome (SARS) in Hong Kong. Environ Health Perspect. 2004;112:1550-1556
9. World Health Organization. WHO Guidelines for the Global Surveillance of Severe Acute Respiratory Syndrome (SARS) Updated Recommendations: October 2004. Geneva, Switzerland: World Health Organization; 2004.
10. Woo CY, Lau KP, Wong HL, et al. Longitudinal profile of immunoglobulin G (IgG), IgM, IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus. Clin Diagn Lab Immunol. 2004;11:665-668
11. Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;9371:1767-1772
12. Chan PK, Ng KC, Chan RC, et al. Immunofluorescence assay for serologic diagnosis of SARS. Emerg Infect Dis. 2004;10:530-532
13. Chan KH, Poon LL, Cheng VC, et al. Detection of SARS coronavirus in patients with suspected SARS. Emerg Infect Dis. 2004;10:294-299
14. KH Chan, VCC Cheng, Woo PCY, et al. Serological response in patients with SARS coronavirus infection and cross reactivity with human coronaviruses 229E, OC43 and NL63. Clin Diagn Lab Immunol. 2005;12:1317-1321
15. Leung GM, Chung PH, Tsang T, et al. SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerg Infect Dis. 2004;10:1653-1656
16. Hong Kong 2001 Population Census. Census and Statistics Department, Hong Kong Special Administrative Region of the People's Republic of China: Hong Kong
17. Leung GM, Lim WW, Ho LM, et al. Seroprevlance of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups: a systematic review. Epidemiol Infect. 2006;134:211-221.
18. Riley S, Fraser C, Donnelly CA, et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science. 2003;300:1961-1966